Experimental Hematology
Volume 34, Issue 11 , Pages 1443-1450 , November 2006

Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature

Received 21 September 2005 ,Revised 24 May 2006 ,Accepted 29 June 2006.

References 

  1. Rowley SD. Practical aspects of stem cell collection. In:  Hoffman R,  Benz E,  Shattil S, et al. editor. Hematology: Basic Principles and Practice. Third Edition. New York, NY: Churchill Livingstone; 2000;p. 1642–1658
  2. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood. 1995;85:588–596
  3. Siena S, Schiavo R, Pedrazzoli P, Carlo-Stella C. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy. J Clin Oncol. 2000;18:1360–1377
  4. Weaver CH, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood. 1995;86:3961–3969
  5. Morris CL, Siegel E, Barlogie B, et al. Mobilization of CD34+ cells in elderly patients (>/= 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen. Br J Haematol. 2003;120:413–423
  6. Haas R, Mohle R, Fruhauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood. 1994;83:3787–3794
  7. Ketterer N, Salles G, Moullet I, et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol. 1998;103:235–242
  8. Cottler-Fox MH, Lapidot T, Petit I, et al. Stem cell mobilization. Hematology (Am Soc Hematol Educ Program). 2003;1:419–437
  9. Tarella C, Caracciolo D, Gavarotti P, et al. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplant. 1995;16:223–228
  10. Ford CD, Lehman C, Strupp A, Kelley L. Comparison of CD34+ cell collection efficiency on the COBE Spectra and Fenwal CS-3000 Plus. J Clin Apher. 2002;17:17–20
  11. Bojko P, Scharifi M, Stossel K, Seeber S. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38– and CD34+49d+ subsets during apheresis. J Cancer Res Clin Oncol. 2002;128:19–28
  12. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol. 1995;13:2547–2555
  13. Weaver CH, Schulman KA, Buckner CD. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Bone Marrow Transplant. 2001;27(Suppl 2):S23–S29
  14. Schwartzberg LS, Birch R, Hazelton B, et al. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematother. 1992;1:317–327
  15. Van Hoef ME. Haematological recovery after high-dose consolidation chemotherapy with peripheral blood progenitor cell rescue: the effects of the mobilization regimen and post-transplant growth factors. Neth J Med. 1998;52:30–39
  16. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood. 1997;89:2233–2258
  17. Bengala C, Fennelly D, Shapiro F, et al. Taxol in combination with cyclophosphamide and G-CSF can improve the mobilization of peripheral blood progenitor cells (PBPCs) in untreated locally advanced ovarian cancer: preliminary report. Blood. 1993;82(Suppl 1):82;(abstract 318)
  18. Fennelly D, Bengala C, Schneider J, et al. Peripheral blood progenitor mobilization using Taxol in combination with cyclophosphamide and G-CSF: quantitation and correlation of CD34+ cell count, colony-forming-unit-granulocyte-macrophage (CFU-GM) and mononuclear cell count. Blood. 1994;84(Suppl 1):105;(abstract 409)
  19. Sutherland DR, Keating A, Nayar R, Anania S, Stewart AK. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp Hematol. 1994;22:1003–1010
  20. Demirer T, Buckner CD, Storer B, et al. Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor. J Clin Oncol. 1998;16:1547–1553
  21. Weaver CH, Schwartzberg LS, Zhen B, et al. Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of 3 vs 4 g/m2 of CY. Bone Marrow Transplant. 1999;23:421–425
  22. Klein J, Rey P, Dansey R, et al. Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells. Bone Marrow Transplant. 1999;24:959–963
  23. Demirer T, Rowley S, Buckner CD, et al. Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer. J Clin Oncol. 1995;13:1714–1719
  24. Weaver CH, Schwartzberg LS, Birch R, et al. Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer. Biol Blood Marrow Transplant. 1997;3:83–90
  25. Haynes A, Hunter A, McQuaker G, Anderson S, Bienz N, Russell NH. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant. 1995;16:359–363
  26. McQuaker I, Haynes A, Stainer C, Byrne J, Russell N. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease. Bone Marrow Transplant. 1999;24:715–722
  27. Lerro KA, Medoff E, Wu Y, et al. A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents. Bone Marrow Transplant. 2003;32:1113–1117
  28. Laport GG, Fleming GF, Waggoner S, Zimmerman TM, Grinblatt DL, Williams SF. A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer. Bone Marrow Transplant. 2001;27:677–681
  29. Arpaci F, Komurcu S, Ozturk B, Ozet A, Kinalp C, Yalcin A. The mobilization with delayed G-CSF administration after standard induction chemotherapy and single standard volume apheresis can supply adequate amount of CD34(+) cells in patients with breast cancer. Haematologica. 2001;86:E01
  30. Bargetzi MJ, Passweg J, Baertschi E, et al. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective. Bone Marrow Transplant. 2003;31:99–103
  31. Lefrere F, Audat F, Hermine O, et al. The timing of granulocyte-colony-stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 cases. Transfusion. 1999;39:561–564
  32. Min YJ, Kim SW, Suh C, et al. The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF. J Korean Med Sci. 2000;15:49–52
  33. Dolgopolov I, Andreeva L, Yankelevich M, Mscheidze D, Siegel S, Mentkevich G. Delayed introduction of G-CSF after chemotherapy does not affect peripheral blood stem cell yield and engraftment kinetics in children with high-risk malignancies: retrospective study of 45 cases. Am J Hematol. 2003;73:225–229
  34. Stewart DA, Guo D, Morris D, et al. Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens. Bone Marrow Transplant. 1999;23:111–117
  35. Benet I, Prosper BF, Marugan I, et al. Mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing chemotherapy followed by autologous peripheral blood stem cell transplant (SCT) for high risk breast cancer (HRBC). Bone Marrow Transplant. 1999;23:1101–1107
  36. Weaver CH, Birch R, Greco FA, et al. Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br J Haematol. 1998;100:338–347
  37. Demirer T, Ayli M, Ozcan M, et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol. 2002;116:468–474
  38. Lefrere F, Belanger C, Audat F, et al. The dose of granulocyte-colony-stimulating factor after chemopriming treatment does not influence apheresis yield of progenitor cells: a retrospective study of 91 cases. Transfusion. 1999;39:1207–1211
  39. Martinez C, Sureda A, Martino R, et al. Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 microg/m2) after salvage chemotherapy for lymphoma. Bone Marrow Transplant. 1997;20:855–858
  40. Desikan KR, Jagannath S, Siegel D, et al. Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma. Leuk Lymphoma. 1998;28:501–508
  41. Comenzo RL, Malachowski ME, Miller KB, et al. Large-volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease. Transfusion. 1995;35:42–45
  42. Smolowicz AG, Villman K, Tidefelt U. Large-volume apheresis for the harvest of peripheral blood progenitor cells for autologous transplantation. Transfusion. 1997;37:188–192
  43. Humpe A, Riggert J, Munzel U, et al. A prospective, randomized, sequential, crossover trial of large-volume versus normal-volume leukapheresis procedures: effect on progenitor cells and engraftment. Transfusion. 1999;39:1120–1127

PII: S0301-472X(06)00457-7

doi: 10.1016/j.exphem.2006.06.022

Experimental Hematology
Volume 34, Issue 11 , Pages 1443-1450 , November 2006

Article Tools